Jun
14
2024
Jun
14
2024
Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress
May
30
2024
May
14
2024
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress
May
13
2024
Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference
May
09
2024
Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update
Apr
01
2024
Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)
Mar
21
2024
Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Mar
06
2024
Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024
Feb
26
2024
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer
Displaying 1 - 10 of 14